A Phase 1, Open-Label, Parallel-Group, Single-Dose Study To Compare The Pharmakokinetics Of TNX-102 SL (Cyclobenzaprine Hydrochloride Sublingual Tablet) In Non-Elderly Versus Elderly Participants

Clinical trial NCT07413367 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07413367
Sponsor: Tonix Pharmaceuticals, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmakokinetic Open Label Phase 1

Start date: 2025-12-09
Primary completion: 2026-02-10
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.